Qinghaosu (Artemisinin): The Price of Success
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Artemisinin and its derivatives have become essential components of antimalarial treatment. These plant-derived peroxides are unique among antimalarial drugs in killing the young intraerythrocytic malaria parasites, thereby preventing their development to more pathological mature stages. This results in rapid clinical and parasitological responses to treatment and life-saving benefit in severe malaria. Artemisinin combination treatments (ACTs) are now first-line drugs for uncomplicated falciparum malaria, but access to ACTs is still limited in most malaria-endemic countries. Improved agricultural practices, selection of high-yielding hybrids, microbial production, and the development of synthetic peroxides will lower prices. A global subsidy would make these drugs more affordable and available. ACTs are central to current malaria elimination initiatives, but there are concerns that tolerance to artemisinins may be emerging in Cambodia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“iron-catalysed radical formation is also significantly involved in the antimalarial (i.e. cytotoxic) mode of action of artemisinin [1494,1496-1504], and this reaction is in fact inhibited by iron chelators [1505] such that a combined artemisinin-chelator therapy would be contraindicated.”
From Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases (2009) · cites this paper as [1504]
Citations
Cites
Lopez, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T., & Murray, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68770-9 · Cited by 5,630
Production of the antimalarial drug precursor artemisinic acid in engineered yeast
Ro, D.-K., Paradise, E. M., Ouellet, M., Fisher, K. J., Newman, K. L., Ndungu, J. M., Ho, K. A., Eachus, R. A., Ham, T. S., Kirby, J., et al. (2006) · Nature · doi:10.1038/nature04640 · Cited by 2,805
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67176-0 · Cited by 1,050
Artemisinins target the SERCA of Plasmodium falciparum
Eckstein-Ludwig, U., Webb, R. J., van Goethem, I. D. A., East, J. M., Lee, A. G., Kimura, M., O'Neill, P. M., Bray, P. G., Ward, S. A., & Krishna, S. (2003) · Nature · doi:10.1038/nature01813 · Cited by 1,027
Bhattarai, A., Ali, A. S., Kachur, S. P., Mårtensson, A., Abbas, A. K., Khatib, R., Al-mafazy, A.-W., Ramsan, M., Rotllant, G., Gerstenmaier, J. F., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040309 · Cited by 647
Identification of an antimalarial synthetic trioxolane drug development candidate
Vennerstrom, J. L., Arbe-Barnes, S., Brun, R., Charman, S. A., Chiu, F. C. K., Chollet, J., Dong, Y., Dorn, A., Hunziker, D., Matile, H., et al. (2004) · Nature · doi:10.1038/nature02779 · Cited by 622
Assessment of the pharmacodynamic properties of antimalarial drugs in vivo
White, N. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1413 · Cited by 575
Self-citationWhite, N., Nosten, F., Looareesuwan, S., Watkins, W., Marsh, K., Snow, R., Kokwaro, G., Ouma, J., Hien, T., Molyneux, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07367-x · Cited by 543
Self-citationArtesunate combinations for treatment of malaria: meta-analysis
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15162-8 · Cited by 538
Self-citationThiers, B. H. (2006) · Yearbook of Dermatology and Dermatologic Surgery · doi:10.1016/s0093-3619(08)70110-2 · Cited by 512
Research works printed but not linked: 11
- Qinghaosu Antimalarial Coordinating Research Group, Chin. Med. J. (Engl.)92, 811 (1979).
- J. B. Jianget al., Lancet2, 285 (1982).
- G. Q. Liet al., J. Tradit. Chin. Med.2, 125 (1982).
- W. Peters, Pharmacol. Ther.47, 499 (1990).
- F. ter Kuileet al., Exp. Parasitol.76, 86 (1993).
- P. Q. Chenet al., Chin. Med. J. (Engl.)107, 709 (1994).
- R. Jambouet al., Lancet366, 1960 (2005). · doi:10.1016/s0140-6736(05)67787-2
- I. Nakase, H. Lai, N. P. Singh, T. Sasaki, Int. J. Pharm.354, 28 (2007).
- International Artemisinin Study Group, Lancet363, 9 (2004). · DOI · Paper page
- M. van Vugt, Am. J. Trop. Med. Hyg.62, 65 (2000).
- Wkly. Epidemiol. Rec.82, 360 (2007).
Cited by
Items 201–300 of 961
Yoo, E., Schulze, C. J., Stokes, B. H., Onguka, O., Yeo, T., Mok, S., Gnädig, N. F., Zhou, Y., Kurita, K. L., Foe, I. T., et al. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.01.001 · Cited by 66
Huang, B., & Zhang, Y. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.02.007 · Cited by 63
Coartem®: the journey to the clinic
Premji, Z. G. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-s1-s3 · Cited by 59
“While parasites from these two patients showed reduced susceptibility in vitro, the authors commented that artemisinin resistance does not seem to be a widespread epidemiologic phenomenon and in a subsequent publication by White et al pointed out that malaria parasites from Western Cambodia are no more resistant in vi…”
BackgroundRichard, D., Bártfai, R., Volz, J. C., Ralph, S. A., Müller, S., Stunnenberg, H. G., & Cowman, A. F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.198499 · Cited by 63
Sesquiterpene lactones from the endemic Cape Verdean Artemisia gorgonum
Ortet, R., Prado, S., Mouray, E., & Thomas, O. (2008) · Phytochemistry · doi:10.1016/j.phytochem.2008.09.022 · Cited by 59
Gemma, S., Campiani, G., Butini, S., Joshi, B. P., Kukreja, G., Coccone, S. S., Bernetti, M., Persico, M., Nacci, V., Fiorini, I., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801352s · Cited by 59
Anthelmintic activity of artesunate against Fasciola hepatica in naturally infected sheep
Keiser, J., Veneziano, V., Rinaldi, L., Mezzino, L., Duthaler, U., & Cringoli, G. (2009) · Research in Veterinary Science · doi:10.1016/j.rvsc.2009.05.007 · Cited by 60
Expanding the Antimalarial Drug Arsenal—Now, But How?
Grimberg, B. T., & Mehlotra, R. K. (2011) · Pharmaceuticals · doi:10.3390/ph4050681 · Cited by 69
“), and is also available as a drug itself [17,18,20].”
BackgroundInfluentialOguri, H., Hiruma, T., Yamagishi, Y., Oikawa, H., Ishiyama, A., Otoguro, K., Yamada, H., & Ōmura, S. (2011) · Journal of the American Chemical Society · doi:10.1021/ja200374q · Cited by 59
Ibrahim, N., Ibrahim, H., Sabater, A. M., Mazier, D., Valentin, A., & Nepveu, F. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.09.020 · Cited by 61
Smith, D. L., Klein, E. Y., McKenzie, F. E., & Laxminarayan, R. (2010) · Malaria Journal · doi:10.1186/1475-2875-9-217 · Cited by 57
Shen, S., Liu, S., Zhang, Y., Du, M., Liang, A., Song, L., & Ye, Z. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s83402 · Cited by 56
“The antimalarial action of artemisinin was quick and without cross-resistance, and it could eliminate almost all asexual and sexual stages of Plasmodium spp..(2,3) correspondence: shu-Zhi liu; Zu-guang Ye Institute of chinese Materia Medica, china academy of chinese Medical sciences, Dongcheng District, Dongzhimen Nan…”
BackgroundAn Artemisinin-Derived Dimer Has Highly Potent Anti-Cytomegalovirus (CMV) and Anti-Cancer Activities
He, R., Mott, B. T., Rosenthal, A. S., Genna, D. T., Posner, G. H., & Arav‐Boger, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024334 · Cited by 63
“Artemisinin monomers are currently the drugs of choice for malaria therapy [14].”
BackgroundLawpoolsri, S., Klein, E. Y., Singhasivanon, P., Yimsamran, S., Thanyavanich, N., Maneeboonyang, W., Hungerford, L. L., Maguire, J. H., & Smith, D. L. (2009) · Malaria Journal · doi:10.1186/1475-2875-8-159 · Cited by 57
Mwanziva, C. E., Shekalaghe, S., Ndaro, A. J., Mengerink, B. B., Megiroo, S., Mosha, F. W., Sauerwein, R. W., DRAKELEY, C. J., Gosling, R. D., & Bousema, T. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-232 · Cited by 61
“Despite this, most fevers are still regarded and treated as malaria, thereby ignoring true causes of febrile illness and over-prescribing ACT.”
BackgroundInfluentialCheng, R., Li, C., Li, C., Wei, L., Li, L., Zhang, Y., Yao, Y., Gu, X., Cai, W., Yang, Z., et al. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11068 · Cited by 56
“ART and its derivatives have a rapid and potent therapeutic effect on the malaria parasite without significant side effects in patients, they are recommended by the World Health Organization as the first-line antimalarial treatment for Plasmodium falciparum malaria.(8)”
BackgroundVerhulst, N. O., Mukabana, W. R., Takken, W., & Smallegange, R. C. (2011) · Entomologia Experimentalis et Applicata · doi:10.1111/j.1570-7458.2011.01119.x · Cited by 61
“Insecticide-treated nets (ITNs) and artemisinin-based therapies have contributed considerably to the reduction in malaria cases in the past decade (Lengeler, 2004; White, 2008; WHO, 2010).”
BackgroundDas, D., Tripura, R., Phyo, A. P., Lwin, K. M., Tärning, J., Lee, S. J., Hanpithakpong, W., Stepniewska, K., Ménard, D., Ringwald, P., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis958 · Cited by 60
“There is evidence that artemisinin resistance particularly involves ring-stage parasites [2, 7, 8].”
BackgroundSelf-citationAn outbreak of artemisinin resistant falciparum malaria in Eastern Thailand
Imwong, M., Jindakhad, T., Kunasol, C., Sutawong, K., Vejakama, P., & Dondorp, A. M. (2015) · Scientific Reports · doi:10.1038/srep17412 · Cited by 58
Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties
Soomro, S., Langenberg, T., Mahringer, A., Konkimalla, V. B., Horwedel, C., Holenya, P., Brand, A., Cetin, C., Fricker, G., Dewerchin, M., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01120.x · Cited by 54
“In spite of its therapeutic utility in treating malaria, resistant strains of the malaria parasites are emerging, mostly in western Cambodia, where treatment failure rates after combination therapy have exceeded 10% [24].”
BackgroundNovel approaches and achievements in biosynthesis of functional isoprenoids in Escherichia coli
Harada, H., & Misawa, N. (2009) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-009-2166-6 · Cited by 56
“…a sesquiterpene artemisinin, isolated from the shoots of annual wormwood, Artemisia annua, has been used as an antimalarial drug (Enserink 2005; White 2008), and a sesquiterpene parthenolide, included in the plant feverfew, Tanacetum parthenium, was found to have anticancer activity (Guzman et…”
BackgroundFeng, M.-X., Hong, J.-X., Wang, Q., Fan, Y., Yuan, C., Lei, X., Zhu, M., Qin, A., Chen, H., & Hong, D. (2016) · Scientific Reports · doi:10.1038/srep19074 · Cited by 56
Fairhurst, R. M., & Wellems, T. E. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00275-7 · Cited by 74
Achieng, A. O., Muiruri, P., Ingasia, L. A. O., Opot, B., Juma, D. W., Yeda, R. A., Ngalah, B. S., Ogutu, B. R., Andagalu, B., Akala, H. M., et al. (2015) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2015.05.005 · Cited by 55
“falciparum parasites are cleared within 48 h in 95% of the patients post-ACTs treatment based on smears (White, 2008) whereas resistant parasites are”
BackgroundEthnopharmacology and Drug Discovery
Heinrich, M. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00666-3 · Cited by 55
Stepniewska, K., Humphreys, G. S., Gonçalves, B. P., Craig, E., Gosling, R. D., Guerin, P. J., Price, R. N., Barnes, K. I., Raman, J., Smit, M. R., et al. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa498 · Cited by 54
“As a result, applyparastyle “fig//caption/p[1]” parastyle “FigCapt””
BackgroundAaMYB15, an R2R3-MYB TF in Artemisia annua, acts as a negative regulator of artemisinin biosynthesis
Wu, Z., Li, L., Liu, H., Yan, X., Ma, Y., Li, Y., Chen, T., Wang, C., Xie, L., Hao, X., et al. (2021) · Plant Science · doi:10.1016/j.plantsci.2021.110920 · Cited by 55
Drug Development Strategies for Malaria: With the Hope for New Antimalarial Drug Discovery—An Update
Pandey, S. K., Anand, U., Siddiqui, W. A., & Tripathi, R. (2023) · Advances in Medicine · doi:10.1155/2023/5060665 · Cited by 55
Engberg, R. M., Grevsen, K., Ivarsen, E., Fretté, X. C., Christensen, L. P., Højberg, O., Jensen, B. B., & Canibe, N. (2012) · Avian Pathology · doi:10.1080/03079457.2012.696185 · Cited by 63
“…decade, artemisinin and its derivatives have been used as key components in the combination therapies against human malaria, caused by protozoan blood parasites (Plasmodium falciparum, Plasmodium vivax) belonging to the class of sporozoa (Douglas et al., 2010, Nosten & White, 2007; White, 2008).”
BackgroundBastiaens, G. J. H., Schaftenaar, E., Ndaro, A. J., Keuter, M., Bousema, T., & Shekalaghe, S. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-76 · Cited by 61
“It is important that diagnosis is established before ACT is prescribed.”
BackgroundInfluentialPlasmodial sugar transporters as anti-malarial drug targets and comparisons with other protozoa
Slavić, K., Krishna, S., Derbyshire, E. T., & Staines, H. M. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-165 · Cited by 51
“falciparum [2-5].”
Quadt, K. A., Barfod, L. K., Andersen, D. B., Bruun, J., Gyan, B. A., Hassenkam, T., Ofori, M. F., & Hviid, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045658 · Cited by 62
“Light microscopy was used to assess the age (time since invasion) of Giemsa-stained IEs on thin smears, using a Olympus CX41 microscope at 1,0006magnification [43,44].”
MethodOverproduction of artemisinin in tetraploid Artemisia annua L.
Banyai, W., Sangthong, R., Karaket, N., Inthima, P., Mii, M., & Supaibulwatana, K. (2010) · Plant Biotechnology · doi:10.5511/plantbiotechnology.10.0726a · Cited by 52
Synthetic chemistry fuels interdisciplinary approaches to the production of artemisinin
Corsello, M. A., & Garg, N. K. (2014) · Natural Product Reports · doi:10.1039/c4np00113c · Cited by 58
Chhibber‐Goel, J., & Sharma, A. K. (2019) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2019.10.001 · Cited by 54
“and causes up to ~10,000 fold reduction in parasites within the first 48 h of administration (Dondorp et al., 2009; White, 2008; Nosten and White, 2007; Witkowski et al., 2013b).”
BackgroundMethodInfluentialSupply and demand—heme synthesis, salvage and utilization by Apicomplexa
Kloehn, J., Harding, C. R., & Soldati‐Favre, D. (2021) · The FEBS Journal · doi:10.1111/febs.15445 · Cited by 52
Zhang, Y. J., Gallis, B. M., Taya, M. D., Wang, S., Ho, R. J. Y., & Sasaki, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059086 · Cited by 51
“ART and its derivatives, alone or in combined therapy, are the standards of care for all forms of malaria[3,4].”
BackgroundMartínez, M. J. A., Bedoya, L. M., Ticona, L. A., & Bermejo, P. (2012) · Studies in natural products chemistry · doi:10.1016/b978-0-444-59514-0.00002-x · Cited by 54
Synthesis, antimalarial activity and cytotoxicity of substituted 3,6-diphenyl-[1,2,4,5]tetraoxanes
Kumar, N., Khan, S. I., Beena, Rajalakshmi, G., Kumaradhas, P., & Rawat, D. S. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.06.020 · Cited by 50
Abbasi, B. A., Iqbal, J., Ahmad, R., Bibi, S., Mahmood, T., Kanwal, S., Bashir, S., Gul, F., & Hameed, S. (2019) · Pharmacological Reports · doi:10.1016/j.pharep.2019.03.001 · Cited by 51
Petersen, I., Gabryszewski, S. J., Johnston, G. L., Dhingra, S. K., Ecker, A., Lewis, R. E., de Almeida, M. J., Straimer, J., Henrich, P. P., Palatulan, E. L., et al. (2015) · Molecular Microbiology · doi:10.1111/mmi.13035 · Cited by 50
“The loss of CQ efficacy across the globe, followed by a short-lived dependence on the sulfadoxine-pyrimethamine antifolates, has resulted in recent years in the global adoption of ACTs (White, 2008; Eastman and Fidock, 2009).”
BackgroundDihydroartemisinin inhibits the human erythroid cell differentiation by altering the cell cycle
Finaurini, S., Basilico, N., Corbett, Y., D’Alessandro, S., Parapini, S., Olliaro, P., Haynes, R. K., & Taramelli, D. (2012) · Toxicology · doi:10.1016/j.tox.2012.05.024 · Cited by 51
Treatment and Prevention of Malaria
Staines, H. M., & Krishna, S. (2012) · Springer eBooks · doi:10.1007/978-3-0346-0480-2 · Cited by 56
Synthesis and Biological Evaluation of Acridine Derivatives as Antimalarial Agents
Yu, X., Ramiandrasoa, F., Guetzoyan, L. J., Pradines, B., Quintino, E., Gadelle, D., Forterre, P., Cresteil, T., Mahy, J., & Pèthe, S. (2012) · ChemMedChem · doi:10.1002/cmdc.201100554 · Cited by 50
Elfadadny, A., Ragab, R. F., Hamada, R., Jaouni, S. K. A., Fu, J., Mousa, S. A., & El‐Far, A. H. (2023) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2023.116405 · Cited by 52
Synthetic Strategies for Peroxide Ring Construction in Artemisinin
Андреевна, В. В., Yaremenko, I. A., Ilovaisky, A. I., & Terent'ev, A. O. (2017) · Molecules · doi:10.3390/molecules22010117 · Cited by 54
“The availability of artemisinin-based drugs is largely limited by their high cost [17,18].”
BackgroundTargeting the apicoplast in malaria
Biddau, M., & Sheiner, L. (2019) · Biochemical Society Transactions · doi:10.1042/bst20170563 · Cited by 51
Murithi, J. M., Pascal, C., Bath, J., Boulenc, X., Gnädig, N. F., Pasaje, C. F. A., Rubiano, K., Yeo, T., Mok, S., Klieber, S., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abg6013 · Cited by 49
Tadesse, F. G., Lanke, K. H. W., Nébié, I., Schildkraut, J. A., Gonçalves, B. P., Tiono, A. B., Sauerwein, R. W., DRAKELEY, C. J., Bousema, T., & Rijpma, S. R. (2017) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0893 · Cited by 43
“of posttreatment gametocyte dynamics when the asexual parasite biomass is typically reduced by > 99%within days after initiation of treatment.(34)”
BackgroundLaboratory Detection of Artemisinin-Resistant Plasmodium falciparum
Chotivanich, K., Tripura, R., Das, D., Yi, P., Day, N., Pukrittayakamee, S., Chuor, C. M., Socheat, D., Dondorp, A. M., & White, N. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01924-13 · Cited by 52
“carriage (2, 3), while the partner drugs in ACTs are eliminated”
BackgroundSelf-citationKaushik, N. K., Murali, T. S., Sahal, D., & Suryanarayanan, T. S. (2014) · Acta Parasitologica · doi:10.2478/s11686-014-0307-2 · Cited by 47
“…sesquiterpene lactone of the Chinese herb Artemisia annua L., and its synthetic analogues are very effective in controlling drug-resistant malaria (White 2008), a recent report indicates the emergence of artemisinin-resistant malarial parasite strains in western Cambodia and western Thailand…”
BackgroundUpdates on artemisinin: an insight to mode of actions and strategies for enhanced global production
Pandey, N., & Rai, S. P. (2015) · PROTOPLASMA · doi:10.1007/s00709-015-0805-6 · Cited by 54
Maity, S., Parhi, B., & Ghorai, P. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201511165 · Cited by 48
Malaria medicines to address drug resistance and support malaria elimination efforts
Achan, J., Mwesigwa, J., Edwin, C. P., & D’Alessandro, U. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1387773 · Cited by 47
“These artemisinin derivatives possess several important pharmacological characteristics, including rapid onset of action, short half-life, activity against multiple stages of the malaria parasite life cycle, and an excellent safety profile [19].”
BackgroundKrieger, J., Smeilus, T., Kaiser, M., Seo, E., Efferth, T., & Giannis, A. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201802015 · Cited by 48
Enhanced artemisinin yield by expression of rol genes in Artemisia annua.
Dilshad, E., Cusido, R. M., Palazon, J., Estrada, K. R., Bonfill, M., & Mirza, B. (2015) · Malaria Journal · doi:10.1186/s12936-015-0951-5 · Cited by 47
“Background Artemisinin, a highly potent anti-malarial agent found in the medicinal plant Artemisia annua, is part of the artemisinin-based combination therapy recommended by the World Health Organization for the treatment of malaria [1, 2].”
BackgroundYe, V. M., & Bhatia, S. K. (2011) · Biotechnology Journal · doi:10.1002/biot.201100289 · Cited by 48
“Yet, access to ACTs is limited in malaria-endemic countries [43].”
BackgroundHou, L., He, S., Wang, J., Yang, Y., Zhu, F., Zhou, Y., He, P., Zhang, Y., Yang, Y., Li, Y., et al. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.09.003 · Cited by 48
“Derivatives of artemisinin are currently recommended as first-line antimalarial agent [1].”
BackgroundInsight into the mechanism of action of plakortins, simple 1,2-dioxaneantimalarials
Taglialatela‐Scafati, O., Fattorusso, E., Romano, A., Scala, F., Barone, V., Cimino, P., Stendardo, E., Catalanotti, B., Persico, M., & Fattorusso, C. (2009) · Organic & Biomolecular Chemistry · doi:10.1039/b918600j · Cited by 47
Ma, X., Nong, C., Liang, Y.-F., Xu, P.-P., Guo, X.-Y., Liang, C., Pan, C., Su, G., & Mo, D. (2020) · Green Chemistry · doi:10.1039/d0gc00929f · Cited by 47
Chen, Y., Zhang, H., Zhang, M., Zhang, W., Ou, Z., Peng, Z., Fu, C., Zhao, C., & Yu, L. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.697476 · Cited by 46
“Similar to other secondary plant metabolites, such as artemisinin and vinblastine, taxol is very rare in vivo (Kwak et al., 1995; White, 2008; Abdul Rahim et al., 2018).”
BackgroundAlcântara, D. D. F. Á., Ribeiro, H. F., Cardoso, P. C. D. S., Araújo, T. M. T., Burbano, R. M. R., Guimarães, A. C., Khayat, A. S., & Bahia, M. D. O. (2011) · Journal of Applied Toxicology · doi:10.1002/jat.1734 · Cited by 46
“Artemisinin is a sesquiterpene lactone endoperoxide found in the traditional Chinese medicinal plant Artemisia annua and extensively used as an antimalarial drug (Boareto et al., 2008; White, 2008).”
BackgroundMetabolic engineering of chloroplasts for artemisinic acid biosynthesis and impact on plant growth
Saxena, B., Subramani, M., Malhotra, K., Bhavesh, N. S., Potlakayala, S. D., & Kumar, S. B. (2014) · Journal of Biosciences · doi:10.1007/s12038-013-9402-z · Cited by 46
“Scientific efforts were made to enhance artemisinin production via plant breeding (White, 2008) as well as through genetic engineering approaches in A. annua (Chen et al. 2000; Zhang et al. 2008), none of which have been successful due to poor plant regeneration and transformation frequency…”
BackgroundKumar, N., Khan, S. I., Sharma, M. M., Atheaya, H., & Rawat, D. S. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.01.103 · Cited by 47
Exploring Chemical and Biological Space of Terpenoids
Zeng, T., Liu, Z., Liu, H., He, W., Tang, X., Xie, L., & Wu, R. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00443 · Cited by 49
Huang, X., Liu, M., Li, J., Zhou, X., & ten Cate, J. M. (2012) · International Journal of Oral Science · doi:10.1038/ijos.2012.44 · Cited by 46
Study towards improving artemisinin-based combination therapies
Lyu, H., Ma, N., Meng, Y., Zhang, X., Wong, Y., Xu, C., Liao, F., Jiang, T., Tu, Y., & Wang, J. (2021) · Natural Product Reports · doi:10.1039/d0np00079e · Cited by 50
Recent advances in novel heterocyclic scaffolds for the treatment of drug-resistant malaria
Kumar, S., Singh, R. K., Patial, B., Goyal, S., & Bhardwaj, T. (2015) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2015.1016513 · Cited by 43
Kazakova, O., Kazakov, D., Yamansarov, E. Y., Medvedeva, N., Tolstikov, G., Suponitsky, K., & Arkhipov, D. (2011) · Tetrahedron Letters · doi:10.1016/j.tetlet.2010.12.047 · Cited by 45
Wang, Z., Parker, D. M., Hao, M., Wu, L., Li, J., Zhao, Z., Zhang, R., Fan, Q., Wang, H., Cui, L., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030927 · Cited by 45
“Artemisinin and its derivatives are by far the most potent antimalarial drugs [2], and at present, our last line of defense against multidrug resistant parasites.”
BackgroundJohnston, G. L., Gething, P. W., Hay, S. I., Smith, D. L., & Fidock, D. A. (2014) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003434 · Cited by 45
“endemic world [4,5].”
Keiser, J., Sayed, H. A. E., El-Ghannam, M., Sabry, H., Anani, S., Wakeel, A. E., Hatz, C., Utzinger, J., el-Din, S. H. S., El-Maadawy, W. H., et al. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001285 · Cited by 48
“Artemether (monotherapy) was administered following the dosing regimen of a commonly used ACT, the 6-dose regimen of artemether-lumefantrine [21], and a previously employed 3-dose malaria treatment schedule administered on a single day [22].”
BackgroundInfluentialNgum, W. P., Hastings, I. M., Dondorp, A. M., White, L. J., Maude, R. J., Saralamba, S., Day, N., White, N. J., & Boni, M. F. (2009) · Evolutionary Applications · doi:10.1111/j.1752-4571.2008.00067.x · Cited by 52
“For artemisinins, a is usually zero or if it exists is extremely small because the elimination half-life of the artemisinin is only 1 h in comparison with the ‡48 h asexual cycle of the malaria parasites (Stepniewska and White 2008).”
BackgroundMethodInfluentialSelf-citationPrice subsidies increase the use of private sector ACTs: evidence from a systematic review
Morris, A., Ward, A., Moonen, B., Sabot, O. J., & Cohen, J. M. (2014) · Health Policy and Planning · doi:10.1093/heapol/czu013 · Cited by 44
Pereira, M. R., Henrich, P. P., Sidhu, A. B. S., Johnson, D., Hardink, J. R., Deusen, J. V., Lin, J., Gore, K., O’Brien, C., Wélé, M., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01566-10 · Cited by 45
“In the last decade, artemisinin-based combination therapies (ACTs) have become widely adopted as first-line treatment in almost all countries where malaria is endemic (90).”
BackgroundSheng, H., Zeng, R., Wang, W., Luo, S., Feng, Y., Liu, J. L., Chen, W., Zhu, M., & Guo, Q. (2017) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.201600373 · Cited by 44
Musonda, C. C., Whitlock, G. A., Witty, M. J., Brun, R., & Kaiser, M. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.11.098 · Cited by 44
Ajuga remota Benth.: From ethnopharmacology to phytomedical perspective in the treatment of malaria
Cocquyt, K., Cos, P., Herdewijn, P. A., Maes, L. J. R. M., den Steen, P. E. V., & Laekeman, G. (2011) · Phytomedicine · doi:10.1016/j.phymed.2011.08.063 · Cited by 43
Inferred relatedness and heritability in malaria parasites
Anderson, T., Williams, J. T., Nair, S., Sudimack, D., Barends, M., Jaidee, A., Price, R. N., & Nosten, F. H. (2010) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2010.0196 · Cited by 42
“Typically, 95 per cent of patients are parasite-negative by day 2 of treatment (White 2008).”
BackgroundInfluentialWu, X., Liu, Y., Zhang, E., Chen, J., Huang, X., Yan, H., Cao, W., Qu, J., Gu, H., Xu, R., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6096391 · Cited by 44
“Dihydroartemisinin (DHA), a derivative and active metabolite of artemisinin isolated from the traditional Chinese herb Artemisia annua, has been widely used as a first-line antimalarial therapy [4, 5].”
BackgroundLi, Y., Chen, T., Wang, W., Liu, H., Yan, X., Wu-Zhang, K., Qin, W. D., Xie, L., Zhang, Y., Peng, B., et al. (2021) · Plant Methods · doi:10.1186/s13007-021-00807-5 · Cited by 45
Identification and Optimization of an Aminoalcohol-Carbazole Series with Antimalarial Properties
Molette, J., Routier, J., Abla, N., Besson, D., Bombrun, A., Brun, R., Burt, H. J., Georgi, K., Kaiser, M., Nwaka, S., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400015f · Cited by 43
Memvanga, P. B., & Véronique Préat, A. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.05.004 · Cited by 50
“and to kill immature and developing gametocytes, the sexual stages that are essential for transmission [2,4,5].”
BackgroundThe Antimalarial Trioxaquine DU1301 Alkylates Heme in Malaria-Infected Mice
Garah, F. E., Claparols, C., Benoit‐Vical, F., Meunier, B., & Robert, A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00165-08 · Cited by 43
“In addition, no clinically relevant parasite resistance has been reported so far (7, 24, 25).”
BackgroundNatural product databases for drug discovery: Features and applications
Zeng, T., Li, J., & Wu, R. (2024) · Pharmaceutical Science Advances · doi:10.1016/j.pscia.2024.100050 · Cited by 71
Fernández, I., & Robert, A. (2011) · Organic & Biomolecular Chemistry · doi:10.1039/c1ob05088e · Cited by 42
Guanacastane-type diterpenoids from Coprinus radians
Ou, Y., Li, Y., Qian, X., & Shen, Y. (2012) · Phytochemistry · doi:10.1016/j.phytochem.2012.03.002 · Cited by 42
Novel in vivo active anti-malarials based on a hydroxy-ethyl-amine scaffold
Ciana, C., Siegrist, R., Aissaoui, H., Marx, L., Racine, S., Meyer, S., Binkert, C., de Kanter, R., Fischli, C., Wittlin, S., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.11.118 · Cited by 42
Cai, S., Risinger, A. L., Nair, S., Peng, J., Anderson, T. J. C., Du, L., Powell, D. R., Mooberry, S. L., & Cichewicz, R. H. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00874 · Cited by 43
Adrenal hormones mediate disease tolerance in malaria
Vandermosten, L., Pham, T., Knoops, S., Geest, C. D., Lays, N., der Molen, K. V., Kenyon, C. J., Verma, M., Chapman, K. E., Schuit, F. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06986-5 · Cited by 47
Arora, M., Saxena, P., Abdin, M. Z., & Varma, A. (2018) · Symbiosis · doi:10.1007/s13199-017-0519-y · Cited by 41
“The plant has been used from ancient time in traditional medicine as well as in modern pharmacology (Abdin et al. 2003; White 2008).”
MethodJacobs, L., de Kock, C. A., de Villiers, K. A., Smith, P. J., Smith, V. J., van Otterlo, W. A. L., & Blackie, M. (2015) · ChemMedChem · doi:10.1002/cmdc.201500349 · Cited by 42
Souza, R. M. C., Montenegro, L. M. L., Ferreira, L. K. M., Pereira, V. R. A., Santos, A. C. D. S., Dantas, W. M., Silva, C. J. O. E., Brito, R. M. D. M., Andrade, J. L., de Andrade‐Neto, V. F., et al. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115400 · Cited by 41
Cui, L., Wang, Z., Jiang, H., Parker, D. M., Wang, H., Su, X., & Cui, L. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05943-11 · Cited by 48
“ARTs contain an endoperoxide bridge that is essential for the parasite-killing activities (60).”
BackgroundTarget Identification and Validation of Novel Antimalarials
McNamara, C. W., & Winzeler, E. A. (2011) · Future Microbiology · doi:10.2217/fmb.11.45 · Cited by 49
“In the last few years, field surveillance has detected parasites with a reduced ART susceptibility in western Cambodia [1–3], a locale where resistance has often emerged first [4].”
BackgroundSachanonta, N., Chotivanich, K., Chaisri, U., Turner, G. D. H., Ferguson, D. J. P., Day, N., & Pongponratn, E. (2011) · Ultrastructural Pathology · doi:10.3109/01913123.2011.601405 · Cited by 41
Krungkrai, S. R., & Krungkrai, J. (2016) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2016.04.012 · Cited by 47
Zhang, Y., Yang, J., Wen, Z., Chen, X., Yu, J. H., Yuan, D., Xu, B., Luo, H., & Zhu, J. (2020) · Aging · doi:10.18632/aging.103178 · Cited by 47
“Approximately 40% of all drugs in the world are directly or indirectly derived from natural products, such as artemisinin, a notable success story of a drug discovered from traditional Chinese medicine [32, 33].”
BackgroundChallenges facing drug development for malaria
Craft, J. C. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.09.003 · Cited by 51
Malaria drug resistance: new observations and developments
Sá, J. M., Chong, J. L., & Wellems, T. E. (2011) · Essays in Biochemistry · doi:10.1042/bse0510137 · Cited by 41
“However, these compounds have extremely short half‐lives (typically ~1 h in vivo [28]), which may be a reason for high rates of recrudescence after ART monotherapy [28].”
Metadata
- Authors
- White, N. J.
- Affiliations
- Mahidol University (TH)
- Corresponding author
- White, N. J.
- ORCID
- White, N. J.
- Venue
- Science
- Published
- 2008-04-18
- Volume
- 320
- Issue
- 5874
- Pages
- 330-334
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2076029682
- Cited by
- 954
- References
- 53
- Citations by year
- 2026: 17 · 2025: 37 · 2024: 42 · 2023: 32 · 2022: 32 · 2021: 39 · 2020: 86 · 2019: 48 · 2018: 37 · 2017: 57 · 2016: 61 · 2015: 57 · 2014: 41 · 2013: 54 · 2012: 72
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Phytochemical compounds biological activities
- Keywords
- artemisinin, Artemisia annua, artemisinin-based combination therapy, antimalarial drugs, drug affordability, malaria treatment, falciparum malaria, artemisinin resistance, agricultural practices, drug pricing
- MeSH terms
- Animals, Antimalarials, Drug Resistance, Drug Therapy, Combination, Health Services Accessibility, Humans, Plasmodium falciparum, Drug Costs, Malaria, Falciparum, Cost of Illness, Artemisia, Artemisinins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.